The novel function of advanced glycation end products in regulation of MMP-9 production

Journal of Surgical Research

Volumn 171, Issue 2, 2011, Pages 871-876

  Zhang, Fan ^a   Banker, Greg ^a   Liu, Xiaodong ^a   Suwanabol, Pasithorn A ^a   Lengfeld, Justin ^a   Yamanouchi, Dai ^a   Kent, K Craig ^a   Liu, Bo ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

abdominal aortic aneurysm; MAP kinases; signaling; TGF beta

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SYNAPTOTAGMIN I; TRANSFORMING GROWTH FACTOR BETA; UO 126; WORTMANNIN;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; ENZYME ACTIVITY; GENE DELETION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SUPERNATANT; WESTERN BLOTTING;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; BONE MARROW CELLS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MACROPHAGES, PERITONEAL; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MICE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; TRANSFORMING GROWTH FACTOR BETA;

EID: 81155139257     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.04.027     Document Type: Article

References (41)

1. A. Goldin, J.A. Beckman, and A.M. Schmidt Advanced glycation end products: Sparking the development of diabetic vascular injury Circulation 114 2006 597
2. H.J. Luth, V. Ogunlade, and B. Kuhla Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains Cereb Cortex 15 2005 211
3. M.E. Suliman, O. Heimburger, and P. Barany Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy J Am Soc Nephrol 14 2003 1614
4. R. Ramasamy, S.J. Vannucci, and S.S. Yan Advanced glycation end products and RAGE: A common thread in aging, diabetes, neurodegeneration, and inflammation Glycobiology 15 2005 16R
5. A.M. Schmidt, S.D. Yan, and S.F. Yan The biology of the receptor for advanced glycation end products and its ligands Biochim Biophys Acta 1498 2000 99
6. A.M. Schmidt, M. Vianna, and M. Gerlach Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface J Biol Chem 267 1992 14987
7. B.I. Hudson, M.H. Stickland, and P.J. Grant Characterization of allelic and nucleotide variation between the RAGE gene on chromosome 6 and a homologous pseudogene sequence to its 5' regulatory region on chromosome 3: Implications for polymorphic studies in diabetes Diabetes 50 2001 2646
8. T. Wendt, L. Bucciarelli, and W. Qu Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: Insights into the pathogenesis of macrovascular complications in diabetes Current Atheroscler Rep 4 2002 228
9. R. Ramasamy, S.F. Yan, and A.M. Schmidt The RAGE axis and endothelial dysfunction: Maladaptive roles in the diabetic vasculature and beyond Trends Cardiovasc Med 15 2005 237
10. F. Zhang, K.C. Kent, and D. Yamanouchi Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm Ann Surg 250 2009 416
11. J. Dai, F. Losy, and A.M. Guinault Overexpression of transforming growth factor- β1 stabilizes already-formed aortic aneurysms: A first approach to induction of functional healing by endovascular gene therapy Circulation 112 2005 1008
12. G.G. Vaday, H. Schor, and M.A. Rahat Transforming growth factor-β suppresses tumor necrosis factor α-induced matrix metalloproteinase-9 expression in monocytes J Leukoc Biol 69 2001 613
13. T. Okamoto, S. Takahashi, and E. Nakamura Transforming growth factor-β1 induces matrix metalloproteinase-9 expression in human meningeal cells via ERK and Smad pathways Biochem Biophys Res Commun 383 2009 475
14. F. Zhang, S. Tsai, and K. Kato Transforming growth factor-β promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells J Biol Chem 284 2009 17564
15. S. Singh, and B.B. Aggarwal Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF- κB J Biol Chem 270 1995 10631
16. T. Freestone, R.J. Turner, and A. Coady Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm Arterioscler Thromb Vasc Biol 15 1995 1145
17. R.W. Thompson, D.R. Holmes, and R.A. Mertens Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages J Clin Invest 96 1995 318
18. M. Kazi, C. Zhu, and J. Roy Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm Arterioscler Thromb Vasc Biol 25 2005 1341
19. G.M. Longo, W. Xiong, and T.C. Greiner Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms J Clin Invest 110 2002 625
20. D. Petrinec, S. Liao, and D.R. Holmes Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: Preservation of aortic elastin associated with suppressed production of 92 kD gelatinase J Vasc Surg 23 1996 336
21. R. Pyo, J.K. Lee, and J.M. Shipley Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms J Clin Invest 105 2000 1641
22. S.F. Yan, R. Ramasamy, and A.M. Schmidt The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease Expert Rev Mol Med 11 2009 e9
23. A. Taguchi, D.C. Blood, and G. del Toro Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases Nature 405 2000 354
24. K.M. Khan, L.R. Howe, and D.J. Falcone Extracellular matrix-induced cyclooxygenase-2 regulates macrophage proteinase expression J Biol Chem 279 2004 22039
25. A. Maddahi, Q. Chen, and L. Edvinsson Enhanced cerebrovascular expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 via the MEK/ERK pathway during cerebral ischemia in the rat BMC Neurosci 10 2009 56
26. S.K. Moon, B.Y. Cha, and C.H. Kim ERK1/2 mediates TNF-α-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF- κB and AP-1: Involvement of the ras dependent pathway J Cell Physiol 198 2004 417
27. Y. Zhang, J.C. Naggar, and C.M. Welzig Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: Possible role of ERK Arterioscler Thromb Vasc Biol 29 2009 1764
28. Y.S. Lee, H.T. Lan Tran, and Q. Van Ta Regulation of expression of matrix metalloproteinase-9 by JNK in Raw 264.7 cells: Presence of inhibitory factor(s) suppressing MMP-9 induction in serum and conditioned media Exp Mol Med 41 2009 259
29. K. Yoshimura, H. Aoki, and Y. Ikeda Identification of c-Jun N-terminal kinase as a therapeutic target for abdominal aortic aneurysm Ann N Y Acad Sci 1085 2006 403
30. K. Yoshimura, H. Aoki, and Y. Ikeda Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase in mice Ann N Y Acad Sci 1085 2006 74
31. K. Yoshimura, H. Aoki, and Y. Ikeda Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase Nat Med 11 2005 1330
32. O. Eickelberg, E. Kohler, and F. Reichenberger Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-β1 and TGF-β3 Am J Physiol 276 1999 L814
33. A.B. Roberts, and M.B. Sporn Physiological actions and clinical applications of transforming growth factor-β (TGF-β) Growth Factors 8 1993 1
34. T. Kobayashi, S. Hattori, and H. Shinkai Matrix metalloproteinases-2 and -9 are secreted from human fibroblasts Acta Derm Venereol 83 2003 105
35. T. Salo, J.G. Lyons, and F. Rahemtulla Transforming growth factor-β a 1 up-regulates type IV collagenase expression in cultured human keratinocytes J Biol Chem 266 1991 11436
36. D. Dang, Y. Yang, and X. Li Matrix metalloproteinases and TGFβ1 modulate oral tumor cell matrix Biochem Biophys Res Commun 316 2004 937
37. W.H. Pearce, and A.E. Koch Cellular components and features of immune response in abdominal aortic aneurysms Ann N Y Acad Sci 800 1996 175
38. R. Singh, A. Barden, and T. Mori Advanced glycation end-products: A review Diabetologia 44 2001 129
39. L.G. Bucciarelli, M. Kaneko, and R. Ananthakrishnan Receptor for advanced-glycation end products: Key modulator of myocardial ischemic injury Circulation 113 2006 1226
40. R.W. Thompson, and B.T. Baxter MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial Ann N Y Acad Sci 878 1999 159
41. H. Abdul-Hussien, R. Hanemaaijer, and J.H. Verheijen Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content J Vasc Surg 49 2009 741